REMS
Spectrum:
Absorption: Well absorbed after IM administration. IV administration results in complete bioavailability. Some absorption follows administration by other routes.
Distribution: Widely distributed throughout extracellular fluid; crosses the placenta; small amounts enter breast milk. Poor penetration into CSF.
Half-Life: Neonates <7 days: 311.5 hr; Neonates 730 days: 36 hr; Infants: 35 hr; Children: 13 hr; Adolescents: 0.52.5 hr; Adults: 24 hr (↑ in renal impairment).
ROUTE | ONSET | PEAK | DURATION |
IM | rapid | 3090 min | 824 hr |
IV | rapid | 1530 min‡ | 824 hr |
‡All parenterally administered aminoglycosides.
‡Post-distribution peak occurs 30 min after the end of a 30-min infusion and 15 min after the end of a 1-hr infusion.
Contraindicated in:
Use Cautiously in:
EENT: ototoxicity (vestibular and cochlear)
GU: nephrotoxicity
MS: muscle paralysis (high parenteral doses)
Misc: hypersensitivity reactions
Drug-drug:
Renal Impairment
Lab Test Considerations:
Toxicity and Overdose:
IV Administration: